Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review.
Ansart M, Epelbaum S, Bassignana G, Bône A, Bottani S, Cattai T, Couronné R, Faouzi J, Koval I, Louis M, Thibeau-Sutre E, Wen J, Wild A, Burgos N, Dormont D, Colliot O, Durrleman S. Ansart M, et al. Among authors: koval i. Med Image Anal. 2021 Jan;67:101848. doi: 10.1016/j.media.2020.101848. Epub 2020 Oct 6. Med Image Anal. 2021. PMID: 33091740
AD Course Map charts Alzheimer's disease progression.
Koval I, Bône A, Louis M, Lartigue T, Bottani S, Marcoux A, Samper-González J, Burgos N, Charlier B, Bertrand A, Epelbaum S, Colliot O, Allassonnière S, Durrleman S. Koval I, et al. Sci Rep. 2021 Apr 13;11(1):8020. doi: 10.1038/s41598-021-87434-1. Sci Rep. 2021. PMID: 33850174 Free PMC article.
Forecasting individual progression trajectories in Alzheimer's disease.
Maheux E, Koval I, Ortholand J, Birkenbihl C, Archetti D, Bouteloup V, Epelbaum S, Dufouil C, Hofmann-Apitius M, Durrleman S. Maheux E, et al. Among authors: koval i. Nat Commun. 2023 Feb 10;14(1):761. doi: 10.1038/s41467-022-35712-5. Nat Commun. 2023. PMID: 36765056 Free PMC article.
Determining Recommended Acceptable Intake Limits for N-Nitrosamine Impurities in Pharmaceuticals: Development and Application of the Carcinogenic Potency Categorization Approach (CPCA).
Kruhlak NL, Schmidt M, Froetschl R, Graber S, Haas B, Horne I, Horne S, King ST, Koval IA, Kumaran G, Langenkamp A, McGovern TJ, Peryea T, Sanh A, Ferreira AS, van Aerts L, Vespa A, Whomsley R. Kruhlak NL, et al. Among authors: koval ia. Regul Toxicol Pharmacol. 2024 May 14:105640. doi: 10.1016/j.yrtph.2024.105640. Online ahead of print. Regul Toxicol Pharmacol. 2024. PMID: 38754805 Free article.
80 results